Bakas S, Sako C, Akbari H, Bilello M, Sotiras A, Shukla G, Rudie JD, Santamaría NF, Kazerooni AF, Pati S, Rathore S, Mamourian E, Ha SM, Parker W, Doshi J, Baid U, Bergman M, Binder ZA, Verma R, Lustig RA, Desai AS, Bagley SJ, Mourelatos Z, Morrissette J, Watt CD, Brem S, Wolf RL, Melhem ER, Nasrallah MP, Mohan S, O'Rourke DM, Davatzikos C The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics , Sci Data, 9(1): 2022

Nelson N, Priore S, Sondermann J, Herlihy S, Watt CD Evaluation of Positive Control Material for MGMT Promoter Methylation Studies , Journal of Molecular Diagnostics, 23(11): 2021,1618

Gentile C, Richard-Greenblatt M, Fink J, Elkan M, Harris RM, Van Deerlin VM, Glaser L, Watt CD, Herlihy SE A Practical Comparison of Seven Molecular SARS-CoV-2 Methods , The Journal of Molecular Diagnostics, 22(11): 2020,S33

Zhang Q, Orlando EJ, Wang HY, Bogusz AM, Liu X, Lacey SF, Strauser HT, Nunez-Cruz S, Nejati R, Zhang P, Brooks S, Watt CD, Melenhorst JJ, June CH, Schuster SJ, Wasik MA Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome , Blood, 136(17): 2020,1980-1983

Herlihy SE, Carlin A, Nasrallah NP, Watt CD and Van Deerlin VM Evaluation of a Targeted Realtime Assay for Rapid Identification of IDH1 and IDH2 Disease-Associated Variants in Brain Tumors , The Journal of Molecular Diagnostics, 21(6): 2019,1201

Garces S, Nelson N, Watt CD, and Priore S FLT3 Variants Near Codon 835: An Institutional Experience Comparing Rapid Restriction Digest Testing with Massively Parallel Sequencing. , The Journal of Molecular Diagnostics, 21(6): 2019,1230

McMahon C, Ferng T, Canaani J, Wang E, Morrissette J, Eastburn D, Pellegrino M, Durruthy-Durruthy R, Watt CD, Asthana S, Lasater E, DeFilippis RA, Peretz C, McGary L, Deihimi S, Logan A, Luger S, Shah N, Carroll M, Smith C, and Perl A Clonal selection with Ras pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia. , Cancer Discovery, 9(8): 2019,1050-1063

Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, and Andruss BF Analytical validation of a highly sensitive, multiplexed chronic myeloid leukemia monitoring system targeting BCR-ABL1 RNA. , The Journal of Molecular Diagnostics, 21(4): 2019,718-733

Nasrallah MP, Binder ZA, Oldridge DA, Zhao J, Lieberman DB, Roth JJ, Watt CD, Sukhadia S, Klinman E, Daber RD, Desai A, O’Rourke DM, and Morrissette JJD Molecular neuropathology in practice: Clinical profiling and integrative analysis of molecular alterations in glioblastoma. , Academic Pathology, 6: 2019,2374289519848353

McMahon CM, Canaani J, Rea B, Sargent R, Watt CD, Morrissette JJD, Carroll M, and Perl AE Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia. , Blood Advances, 3(10): 2019,1581-1585